NCT02039908
Examining Tolerance to CNS Stimulants in ADHD
See it on ClinicalTrials.gov ↗267 people
20.2%
79.8%
54 womenmiddle line = equal numbers213 men
- Phase
- PHASE4
- Paid for by
- Florida International University
- Finished
- 2020-03
- Health conditions
- Attention-deficit/Hyperactivity Disorder
- Who could join
- Anyone
- Ages
- 6 Years – 12 Years
- Average age
- Not reported
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 88.8% · Black / African American 8.2% · More than one race 2.2% · Asian 0.7% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 12 Years.”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Active medical or psychiatric conditions that could be worsened by stimulants”
Study titles and rules are shown in their original English.